Yahoo Finance 
Clinical Diagnostics Global Market Report 2023: Sector to Reach $124.7 Billion by 2028 at a CAGR of 8.56%
Global Clinical Diagnostics Market
Dublin, March 15, 2023 (GLOBE NEWSWIRE) -- The "Clinical Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028" report has been added to ResearchAndMarkets.com's offering.
The global clinical diagnostics market size reached US$ 76.2 Billion in 2022. Looking forward, the publisher expects the market to reach US$ 124.7 Billion by 2028, exhibiting a CAGR of 8.56% during 2022-2028.
Clinical diagnostics refer to the process of detecting, identifying and monitoring a disease through signs, symptoms, health history, and physical examination of a patient. They comprise manufacturing, developing, and selling automated test systems, informatics systems, test kits and specialized quality controls. They assist in disease management to improve health and the overall well-being of patients.
They also aid in the stratification of patients with diverse diseases to provide them with targeted therapy. In addition, they can predict therapeutic efficacy, improve the effectiveness of treatments and avoid long-term complications for patients. As a result, clinical diagnostics find extensive applications in the hospital laboratory, diagnostic laboratory, and point-of-care testing across the globe.
At present, there is a rise in the prevalence of chronic diseases, such as cancer, heart disease, stroke, diabetes, and arthritis, around the world. This, along with the growing adoption of automated platforms for disease prevention, detection, and management, represents one of the key factors driving the market.
Moreover, there is an increase in the practice of lipid panel tests to measure total cholesterol, high-density lipoprotein (HDL) cholesterol, triglycerides, low-density lipoprotein (LDL) cholesterol, HDL ratio, and non-HDL cholesterol. This, coupled with the rising mortality rate due to increasing cardiovascular diseases, is propelling the growth of the market.
Besides this, the rising awareness among individuals about the benefits of laboratory tests is offering lucrative growth opportunities to industry investors.
Apart from this, the increasing utilization of clinical diagnostics by healthcare providers to develop targeted therapies through specific and sensitive diagnostic tests is bolstering the growth of the market. Additionally, the escalating demand for personalized medicine among patients is positively influencing the market.
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Becton Dickinson and Company, bioMerieux SA, Bio-Rad Laboratories Inc., Danaher Corporation, F. Hoffmann-La Roche AG, Qiagen N.V., Quest Diagnostics Incorporated, Siemens AG, Sysmex Corporation and Thermo Fisher Scientific Inc.
Key Questions Answered in This Report
1. What was the size of the global clinical diagnostics market in 2022?
2. What is the expected growth rate of the global clinical diagnostics market during 2023-2028?
3. What has been the impact of COVID-19 on the global clinical diagnostics market?
4. What are the key factors driving the global clinical diagnostics market?
5. What is the breakup of the global clinical diagnostics market based on the test?
6. What is the breakup of the global clinical diagnostics market based on the product?
7. What is the breakup of the global clinical diagnostics market based on the end user?
8. What are the key regions in the global clinical diagnostics market?
9. Who are the key players/companies in the global clinical diagnostics market?
Key Attributes:
Report Attribute | Details |
No. of Pages | 143 |
Forecast Period | 2022 - 2028 |
Estimated Market Value (USD) in 2022 | $76.2 Billion |
Forecasted Market Value (USD) by 2028 | $124.7 Billion |
Compound Annual Growth Rate | 8.5% |
Regions Covered | Global |
Key Topics Covered:
1 Preface
2 Scope and Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Clinical Diagnostics Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Test
6.1 Lipid Panel
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Liver Panel
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Renal Panel
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Complete Blood Count
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Electrolyte Testing
6.5.1 Market Trends
6.5.2 Market Forecast
6.6 Infectious Disease Testing
6.6.1 Market Trends
6.6.2 Market Forecast
6.7 Others
6.7.1 Market Trends
6.7.2 Market Forecast
7 Market Breakup by Product
7.1 Instruments
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Reagents
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Others
7.3.1 Market Trends
7.3.2 Market Forecast
8 Market Breakup by End User
8.1 Hospital Laboratory
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Diagnostic Laboratory
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Point-of-care Testing
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Others
8.4.1 Market Trends
8.4.2 Market Forecast
9 Market Breakup by Region
10 SWOT Analysis
11 Value Chain Analysis
12 Porters Five Forces Analysis
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
For more information about this report visit https://www.researchandmarkets.com/r/aonpea
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
